Objective-It is unknown whether elevated maternal low-density lipoprotein cholesterol (LDL-C) levels lead to dyslipidemia in the offspring. Because this could have important consequences for cardiovascular prevention in mother and child, we explored the relationship between maternal familial hypercholesterolemia (FH) and lipids in adult offspring. Methods and Results-In a large cohort of both Dutch and Canadian origin, we compared lipid profiles between patients, aged 18 to 85 years, who inherited FH maternally (nϭ1069) and those who inherited FH paternally (nϭ1270). This relationship was evaluated using multivariate regression analyses. Levels of total cholesterol (TC), LDL-C, and apolipoprotein B 100 (ApoB100) were significantly elevated in patients who inherited FH maternally compared with patients who inherited FH paternally (adjusted differences in TC: 0.156 mmol/L, Pϭ0.037; LDL-C: 0.187 mmol/L, Pϭ0.012; ApoB: 0.064 g/L, Pϭ0.022). Conclusion-Our data show that maternal hereditary hypercholesterolemia slightly increases TC, LDL-C, and ApoB levels in their offspring later in life. Although the molecular mechanisms underlying these observations still require elucidation, our data suggest that maternal hypercholesterolemia during pregnancy may program lipid metabolism to a certain extent in the fetus. Key Words: cardiovascular disease prevention Ⅲ lipids Ⅲ familial hypercholesterolemia F amilial hypercholesterolemia (FH) is a common autosomal dominant disorder of lipoprotein metabolism, caused by mutations in the low-density lipoprotein receptor (LDLR) gene. 1 As a result, FH patients are exposed to elevated levels of low-density lipoprotein cholesterol (LDL-C) from birth onward and are subsequently predisposed to premature cardiovascular disease (CVD). Lowering LDL-C levels in these patients by means of lipid lowering treatment can significantly prevent or delay the onset of CVD and premature death. 2 In women with FH who wish to become pregnant, the current advice is to discontinue statin therapy to avoid teratogenesis in the unborn infant and to reinstitute statin therapy after lactation is finished. 3,4 Consequently, serum cholesterol levels exhibit a sharp increase, and during gestation this becomes even more pronounced. 5 Several studies suggest that maternal cholesterol is transported from the maternal to the fetal circulation 6,7 and that lipid levels of the mother are closely aligned to those of the fetus in the first 6 months of pregnancy. 8 As a result, fetuses of FH mothers may be exposed to rather high lipid levels.Notably, animal and human studies suggest that there may be a critical window for fetal development where changes in the maternal condition can influence long-term cardiovascular risk in the offspring. At one end of the spectrum, maternal nutrient deprivation is associated with a more atherogenic lipid profile and increased cardiovascular risk in the offspring in adult life. 9,10 Conversely, maternal hyperglycemia, for instance, has been associated with a higher risk of developing metabo...